세계의 헤르니아 메시 디바이스 시장 규모, 점유율, 산업 동향 분석 리포트 : 유형별, 헤르니아 유형별, 지역별 전망과 예측(2023-2030년)
Global Hernia Mesh Devices Market Size, Share & Industry Trends Analysis Report By Type (Synthetic and Biologic), By Hernia Type (Inguinal Hernia, Incisional Hernia, Femoral Hernia, and Others), By Regional Outlook and Forecast, 2023 - 2030
상품코드:1384812
리서치사:KBV Research
발행일:2023년 10월
페이지 정보:영문 260 Pages
라이선스 & 가격 (부가세 별도)
한글목차
헤르니아 메시 디바이스 시장 규모는 예측 기간 중 CAGR 6.9%로 성장하며, 2030년에는 82억 달러에 달할 것으로 예측됩니다. 2022년 시장 규모는 2,004만 7,100개로, 성장률은 6.6%(2019-2022년)입니다.
그러나 일부 환자들은 감염, 만성 통증, 메쉬 이동 등 탈장 메쉬 장비와 관련된 합병증을 경험하기도 합니다. 이러한 합병증은 재수술로 이어질 수 있으며 환자 만족도에 영향을 미치고 의료 비용을 증가시킬 수 있습니다. 감염, 만성 통증, 메쉬 이동과 같은 탈장 메쉬 수술로 인한 합병증은 이러한 장비에 대한 환자의 신뢰와 믿음을 손상시킬 수 있습니다. 합병증을 경험한 환자들은 탈장 수술을 받는 것을 주저하게 되어 시장 성장에 영향을 미칩니다. 탈장 메쉬 기기로 인한 합병증은 제조업체에 대한 소송과 법적 조치로 이어지고 있습니다. 또한 제조업체들은 규제 문제에 직면해 있습니다. 따라서 수술의 어려움과 재수술의 필요성이 시장 성장의 걸림돌로 작용하고 있습니다.
팬데믹은 탈장 메쉬 제품과 같은 의료기기 공급망에 혼란을 일으켰습니다. 봉쇄, 여행 제한, 개인보호구(PPE)(PPE)에 대한 수요 증가는 탈장 메쉬 장비의 생산 및 유통에 영향을 미쳤습니다. 이로 인해 제조 및 배송이 지연되어 의료 시설의 탈장 수술 수행 능력에 영향을 미쳤습니다. 세계 많은 의료 시스템과 정부는 COVID-19 환자를 위한 자원의 우선순위를 정하기 위해 선택적 수술을 연기하거나 취소했습니다. 탈장 수술, 특히 긴급하지 않은 것으로 간주되는 수술은 연기되었습니다. 이로 인해 수술 건수가 감소하여 탈장 메쉬 기기에 대한 수요에 큰 영향을 미쳤습니다.
탈장 유형에 대한 전망
탈장 유형에 따라 시장은 살서제 탈장, 절개 탈장, 허벅지 탈장 및 기타로 분류되며, 2022년에는 살서제 탈장 분야가 시장에서 가장 높은 매출 점유율을 차지했습니다. 살서제 탈장 유병률 증가는 인구 고령화와 생활습관 관련 위험 요소의 영향을 받아 탈장 메쉬 장비에 대한 수요를 촉진하고 있습니다. 살서제 탈장이 더 흔해짐에 따라 의료 서비스 프로바이더는 치료 프로토콜에 탈장 메쉬 장비를 사용하는 경향이 높아지고 있습니다. 탈장 메쉬 장비는 살서제 헤르니아 수복에서 탈장 재발의 위험을 효과적으로 줄일 수 있습니다. 메쉬를 사용하면 더 나은 치료 결과와 환자 만족도를 얻을 수 있으므로 외과 의사와 의료 기관은 이러한 장비를 채택하고 있습니다.
유형별 전망
유형별로 보면 시장은 생물학적 제제와 합성수지 제제로 나뉘며, 2022년에는 생물학적 메쉬 분야가 시장에서 큰 매출 점유율을 차지할 것으로 예상됩니다. 생물학적 메쉬는 자연 조직의 복원 및 리모델링 과정을 촉진합니다. 시간이 지남에 따라 이 메쉬는 점차 환자의 몸에 흡수되어 환자의 조직으로 대체됩니다. 이 기능은 장기적인 구조적 지원이 필요하지만 합성 메쉬와 관련된 합병증 위험이 있는 환자에게 특히 유용합니다. 생물학적 메쉬의 안전성 프로파일은 감염, 오염된 상처, 메쉬 관련 합병증 병력이 있는 환자 등 특정 환자 집단에 대해 우수합니다. 생물학적 메쉬는 감염, 침식, 유착과 같은 합병증이 발생하기 쉽지 않습니다.
지역별 전망
지역별로 시장은 북미, 유럽, 아시아태평양 및 LAMEA로 분석되며, 2022년에는 북미가 가장 높은 매출 점유율을 차지하며 시장을 주도할 것으로 예상됩니다. 북미 시장에는 합성 메쉬, 생물학적 메쉬 및 복합 메쉬를 포함한 다양한 탈장 메쉬 장비가 포함됩니다. 좌식 생활 습관, 노인 인구 증가, 탈장 재발 위험이 높기 때문에 북미 시장 확장을 주도하고 있습니다.
목차
제1장 시장 범위와 조사 방법
시장의 정의
목적
시장 범위
세분화
조사 방법
제2장 시장의 개요
주요 하이라이트
제3장 시장 개요
서론
개요
시장 구성과 시나리오
시장에 영향을 미치는 주요 요인
시장 촉진요인
시장 억제요인
Porter's Five Forces 분석
제4장 세계의 헤르니아 메시 디바이스 시장 : 유형별
세계의 합성 시장 : 지역별
세계의 생물제제 시장 : 지역별
제5장 세계의 헤르니아 메시 디바이스 시장 : 헤르니아 유형별
세계의 서혜부 헤르니아 시장 : 지역별
세계의 복벽 반흔 헤르니아 시장 : 지역별
세계의 대퇴 헤르니아 시장 : 지역별
세계의 기타 시장 : 지역별
제6장 세계의 헤르니아 메시 디바이스 시장 : 지역별
북미
북미의 시장 : 국가별
미국
캐나다
멕시코
기타 북미 지역
유럽
유럽의 시장 : 국가별
독일
영국
프랑스
러시아
스페인
이탈리아
기타 유럽 지역
아시아태평양
아시아태평양의 시장 : 국가별
중국
일본
인도
한국
싱가포르
말레이시아
기타 아시아태평양
라틴아메리카·중동 및 아프리카
라틴아메리카·중동 및 아프리카의 시장 : 국가별
브라질
아르헨티나
아랍에미리트
사우디아라비아
남아프리카공화국
나이지리아
기타 라틴아메리카·중동 및 아프리카
제7장 기업 개요
Becton, Dickinson, and Company
Johnson & Johnson
W L. Gore & Associates, Inc.
Getinge AB(Atrium Medical Corporation)
B Braun Melsungen AG
Baxter International, Inc
Cook Medical, Inc(Cook Group)
Medtronic PLC
Integra LifeSciences Holdings Corporation
Herniamesh Sr.l
제8장 시장의 성공 필수 조건
KSA
영문 목차
영문목차
The Global Hernia Mesh Devices Market size is expected to reach $8.2 billion by 2030, rising at a market growth of 6.9% CAGR during the forecast period. In the year 2022, the market attained a volume of 20,047.1 thousand units, experiencing a growth of 6.6% (2019-2022).
The market in Asia Pacific region is being driven by factors like expanding medical tourism, inexpensive treatment options, technological development, and increasing healthcare reimbursements. Thus, the APAC region generated $1,009.7 million revenue in the market in 2022. Furthermore, the demand for hernia repair devices is rising in Asia, particularly Japan and China, due to the region's large patient population. Many undiagnosed and untreated cases are anticipated to fuel the market expansion in this region, which is expected to experience robust growth. Some of the factors impacting the market are increasing prevalence of hernias, improved fixation techniques, and complications leading to revision surgeries.
The growing prevalence of hernias, including inguinal, incisional, ventral, umbilical, and femoral hernias, is a primary driver of the market. Factors such as an aging population, obesity rates, and lifestyle choices contribute to the rise in hernia cases. As per a report by the National Library of Medicine updated in 2023, there were 32.53 million prevalent cases and 13.02 million incident cases of inguinal, femoral, and abdominal hernias globally in 2019, representing increases of 36.00% and 63.67 %, respectively. Medical conditions like chronic obstructive pulmonary disease, constipation, and other factors that cause chronic coughing or straining can lead to an increased risk of hernias. Additionally, Innovations in mesh fixation techniques, including self-gripping meshes, have simplified the surgical process, and reduced the need for additional fixation devices, making hernia repair procedures more efficient. Improved fixation methods lead to shorter operating times. This is particularly valuable for surgeons and healthcare facilities as it allows for more efficient resource utilization and increased surgeries performed in each time frame. Many advanced fixation techniques are well-suited for minimally invasive surgical procedures, such as laparoscopy and robotic-assisted surgery. The growing adoption of fixation techniques improves the overall quality of hernia repair surgeries. This, in turn, contributes to the sustained growth of the market.
However, some patients experience complications related to hernia mesh devices, such as infections, chronic pain, or mesh migration. These complications can lead to revision surgeries, impacting patient satisfaction and increasing healthcare costs. Complications from hernia mesh procedures, such as infections, chronic pain, or mesh migration, can erode patient confidence and trust in these devices. Patients who experience complications hesitate to undergo further hernia repair surgeries, affecting the market's growth. Complications from hernia mesh devices have led to lawsuits and legal actions against manufacturers. In addition, manufacturers face increased regulatory challenges. Thus, difficulties and the need for revision surgeries challenge the market.
The pandemic caused supply chain disruptions for medical devices, such as hernia mesh products. Lockdowns, travel restrictions, and increased demand for personal protective equipment (PPE) affected the production and distribution of hernia mesh devices. This resulted in manufacturing and delivery delays, affecting healthcare facilities' ability to perform hernia surgeries. Many healthcare systems and governments around the world postponed or canceled elective surgeries to prioritize resources for COVID-19 patients. Hernia repair surgeries, especially those considered non-urgent, were deferred. This significantly impacted the demand for hernia mesh devices, as fewer surgeries were being performed.
Hernia Type Outlook
By hernia type, the market is categorized into inguinal hernia, incisional hernia, femoral hernia, and others. In 2022, the inguinal hernia segment held the highest revenue share in the market. The rising prevalence of inguinal hernias, influenced by aging populations and lifestyle-related risk factors, fuels the demand for hernia mesh devices. As inguinal hernias become more common, healthcare providers are more likely to utilize hernia mesh devices in their treatment protocols. Hernia mesh devices effectively reduce the risk of hernia recurrence in inguinal hernia repair. Using mesh offers better outcomes and patient satisfaction, encouraging surgeons and healthcare facilities to adopt these devices.
Type Outlook
Based on type, the market is bifurcated into biologic and synthetic. In 2022, the biologic mesh segment witnessed a substantial revenue share in the market. Biologic meshes promote the natural tissue repair and remodeling process. Over time, these meshes are gradually absorbed by the patient's body and replaced with their tissue. This feature is especially beneficial for patients who require long-term structural support but may be at risk of synthetic mesh-related complications. The safety profile of biologic meshes is superior for specific patient populations, such as those with infections, contaminated wounds, or a history of mesh-related complications. Biologic meshes are less prone to complications like infection, erosion, or adhesion formation.
Regional Outlook
Region-wise, the market is analysed across North America, Europe, Asia Pacific, and LAMEA. In 2022, the North America region led the market by generating the highest revenue share. The market in North America includes a wide range of hernia mesh devices, including synthetic meshes, biologic meshes, and composite meshes. Sedentary lifestyles, a growing elderly population, and a high risk of hernia recurrence drive North America's market expansion.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton Dickinson and Company, Johnson & Johnson, W. L. Gore & Associates, Inc., Atrium Medical Corporation (Getinge AB), B. Braun Melsungen AG, Baxter International, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Integra LifeSciences Holdings Corporation, and Herniamesh S.r.l.
Scope of the Study
Market Segments covered in the Report:
By Type (Volume, thousand units, USD Million, 2019-2030)
Synthetic
Biologic
By Hernia Type (Volume, thousand units, USD Million, 2019-2030)
Inguinal Hernia
Incisional Hernia
Femoral Hernia
Others
By Geography (Volume, thousand units, USD Million, 2019-2030)
North America
US
Canada
Mexico
Rest of North America
Europe
Germany
UK
France
Russia
Spain
Italy
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific
LAMEA
Brazil
Argentina
UAE
Saudi Arabia
South Africa
Nigeria
Rest of LAMEA
Companies Profiled
Becton Dickinson and Company
Johnson & Johnson
W. L. Gore & Associates, Inc.
Atrium Medical Corporation (Getinge AB)
B. Braun Melsungen AG
Baxter International, Inc.
Cook Medical, Inc. (Cook Group)
Medtronic PLC
Integra LifeSciences Holdings Corporation
Herniamesh S.r.l.
Unique Offerings from KBV Research
Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Global Hernia Mesh Devices Market, by Type
1.4.2 Global Hernia Mesh Devices Market, by Hernia Type
1.4.3 Global Hernia Mesh Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Global Hernia Mesh Devices Market by Type
4.1 Global Synthetic Market by Region
4.2 Global Biologic Market by Region
Chapter 5. Global Hernia Mesh Devices Market by Hernia Type
5.1 Global Inguinal Hernia Market by Region
5.2 Global Incisional Hernia Market by Region
5.3 Global Femoral Hernia Market by Region
5.4 Global Others Market by Region
Chapter 6. Global Hernia Mesh Devices Market by Region
6.1 North America Hernia Mesh Devices Market
6.1.1 North America Hernia Mesh Devices Market by Type
6.1.1.1 North America Synthetic Market by Country
6.1.1.2 North America Biologic Market by Country
6.1.2 North America Hernia Mesh Devices Market by Hernia Type
6.1.2.1 North America Inguinal Hernia Market by Country
6.1.2.2 North America Incisional Hernia Market by Country
6.1.2.3 North America Femoral Hernia Market by Country
6.1.2.4 North America Others Market by Country
6.1.3 North America Hernia Mesh Devices Market by Country
6.1.3.1 US Hernia Mesh Devices Market
6.1.3.1.1 US Hernia Mesh Devices Market by Type
6.1.3.1.2 US Hernia Mesh Devices Market by Hernia Type
6.1.3.2 Canada Hernia Mesh Devices Market
6.1.3.2.1 Canada Hernia Mesh Devices Market by Type
6.1.3.2.2 Canada Hernia Mesh Devices Market by Hernia Type
6.1.3.3 Mexico Hernia Mesh Devices Market
6.1.3.3.1 Mexico Hernia Mesh Devices Market by Type
6.1.3.3.2 Mexico Hernia Mesh Devices Market by Hernia Type
6.1.3.4 Rest of North America Hernia Mesh Devices Market
6.1.3.4.1 Rest of North America Hernia Mesh Devices Market by Type
6.1.3.4.2 Rest of North America Hernia Mesh Devices Market by Hernia Type
6.2 Europe Hernia Mesh Devices Market
6.2.1 Europe Hernia Mesh Devices Market by Type
6.2.1.1 Europe Synthetic Market by Country
6.2.1.2 Europe Biologic Market by Country
6.2.2 Europe Hernia Mesh Devices Market by Hernia Type
6.2.2.1 Europe Inguinal Hernia Market by Country
6.2.2.2 Europe Incisional Hernia Market by Country
6.2.2.3 Europe Femoral Hernia Market by Country
6.2.2.4 Europe Others Market by Country
6.2.3 Europe Hernia Mesh Devices Market by Country
6.2.3.1 Germany Hernia Mesh Devices Market
6.2.3.1.1 Germany Hernia Mesh Devices Market by Type
6.2.3.1.2 Germany Hernia Mesh Devices Market by Hernia Type
6.2.3.2 UK Hernia Mesh Devices Market
6.2.3.2.1 UK Hernia Mesh Devices Market by Type
6.2.3.2.2 UK Hernia Mesh Devices Market by Hernia Type
6.2.3.3 France Hernia Mesh Devices Market
6.2.3.3.1 France Hernia Mesh Devices Market by Type
6.2.3.3.2 France Hernia Mesh Devices Market by Hernia Type
6.2.3.4 Russia Hernia Mesh Devices Market
6.2.3.4.1 Russia Hernia Mesh Devices Market by Type
6.2.3.4.2 Russia Hernia Mesh Devices Market by Hernia Type
6.2.3.5 Spain Hernia Mesh Devices Market
6.2.3.5.1 Spain Hernia Mesh Devices Market by Type
6.2.3.5.2 Spain Hernia Mesh Devices Market by Hernia Type
6.2.3.6 Italy Hernia Mesh Devices Market
6.2.3.6.1 Italy Hernia Mesh Devices Market by Type
6.2.3.6.2 Italy Hernia Mesh Devices Market by Hernia Type
6.2.3.7 Rest of Europe Hernia Mesh Devices Market
6.2.3.7.1 Rest of Europe Hernia Mesh Devices Market by Type
6.2.3.7.2 Rest of Europe Hernia Mesh Devices Market by Hernia Type
6.3 Asia Pacific Hernia Mesh Devices Market
6.3.1 Asia Pacific Hernia Mesh Devices Market by Type
6.3.1.1 Asia Pacific Synthetic Market by Country
6.3.1.2 Asia Pacific Biologic Market by Country
6.3.2 Asia Pacific Hernia Mesh Devices Market by Hernia Type
6.3.2.1 Asia Pacific Inguinal Hernia Market by Country
6.3.2.2 Asia Pacific Incisional Hernia Market by Country
6.3.2.3 Asia Pacific Femoral Hernia Market by Country
6.3.2.4 Asia Pacific Others Market by Country
6.3.3 Asia Pacific Hernia Mesh Devices Market by Country
6.3.3.1 China Hernia Mesh Devices Market
6.3.3.1.1 China Hernia Mesh Devices Market by Type
6.3.3.1.2 China Hernia Mesh Devices Market by Hernia Type
6.3.3.2 Japan Hernia Mesh Devices Market
6.3.3.2.1 Japan Hernia Mesh Devices Market by Type
6.3.3.2.2 Japan Hernia Mesh Devices Market by Hernia Type
6.3.3.3 India Hernia Mesh Devices Market
6.3.3.3.1 India Hernia Mesh Devices Market by Type
6.3.3.3.2 India Hernia Mesh Devices Market by Hernia Type
6.3.3.4 South Korea Hernia Mesh Devices Market
6.3.3.4.1 South Korea Hernia Mesh Devices Market by Type
6.3.3.4.2 South Korea Hernia Mesh Devices Market by Hernia Type
6.3.3.5 Singapore Hernia Mesh Devices Market
6.3.3.5.1 Singapore Hernia Mesh Devices Market by Type
6.3.3.5.2 Singapore Hernia Mesh Devices Market by Hernia Type
6.3.3.6 Malaysia Hernia Mesh Devices Market
6.3.3.6.1 Malaysia Hernia Mesh Devices Market by Type
6.3.3.6.2 Malaysia Hernia Mesh Devices Market by Hernia Type
6.3.3.7 Rest of Asia Pacific Hernia Mesh Devices Market
6.3.3.7.1 Rest of Asia Pacific Hernia Mesh Devices Market by Type
6.3.3.7.2 Rest of Asia Pacific Hernia Mesh Devices Market by Hernia Type
6.4 LAMEA Hernia Mesh Devices Market
6.4.1 LAMEA Hernia Mesh Devices Market by Type
6.4.1.1 LAMEA Synthetic Market by Country
6.4.1.2 LAMEA Biologic Market by Country
6.4.2 LAMEA Hernia Mesh Devices Market by Hernia Type
6.4.2.1 LAMEA Inguinal Hernia Market by Country
6.4.2.2 LAMEA Incisional Hernia Market by Country
6.4.2.3 LAMEA Femoral Hernia Market by Country
6.4.2.4 LAMEA Others Market by Country
6.4.3 LAMEA Hernia Mesh Devices Market by Country
6.4.3.1 Brazil Hernia Mesh Devices Market
6.4.3.1.1 Brazil Hernia Mesh Devices Market by Type
6.4.3.1.2 Brazil Hernia Mesh Devices Market by Hernia Type
6.4.3.2 Argentina Hernia Mesh Devices Market
6.4.3.2.1 Argentina Hernia Mesh Devices Market by Type
6.4.3.2.2 Argentina Hernia Mesh Devices Market by Hernia Type
6.4.3.3 UAE Hernia Mesh Devices Market
6.4.3.3.1 UAE Hernia Mesh Devices Market by Type
6.4.3.3.2 UAE Hernia Mesh Devices Market by Hernia Type
6.4.3.4 Saudi Arabia Hernia Mesh Devices Market
6.4.3.4.1 Saudi Arabia Hernia Mesh Devices Market by Type
6.4.3.4.2 Saudi Arabia Hernia Mesh Devices Market by Hernia Type
6.4.3.5 South Africa Hernia Mesh Devices Market
6.4.3.5.1 South Africa Hernia Mesh Devices Market by Type
6.4.3.5.2 South Africa Hernia Mesh Devices Market by Hernia Type
6.4.3.6 Nigeria Hernia Mesh Devices Market
6.4.3.6.1 Nigeria Hernia Mesh Devices Market by Type
6.4.3.6.2 Nigeria Hernia Mesh Devices Market by Hernia Type
6.4.3.7 Rest of LAMEA Hernia Mesh Devices Market
6.4.3.7.1 Rest of LAMEA Hernia Mesh Devices Market by Type
6.4.3.7.2 Rest of LAMEA Hernia Mesh Devices Market by Hernia Type
Chapter 7. Company Profiles
7.1 Becton, Dickinson, and Company
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Acquisition and Mergers:
7.1.6 SWOT Analysis
7.2 Johnson & Johnson
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental & Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 W. L. Gore & Associates, Inc.
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Product Launches and Product Expansions:
7.3.3 SWOT Analysis
7.4 Getinge AB (Atrium Medical Corporation)
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.4.5 SWOT Analysis
7.5 B. Braun Melsungen AG
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 SWOT Analysis
7.6 Baxter International, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental Analysis
7.6.4 Research & Development Expense
7.6.5 SWOT Analysis
7.7 Cook Medical, Inc. (Cook Group)
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 Medtronic PLC
7.8.1 Company overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expenses
7.8.5 SWOT Analysis
7.9 Integra LifeSciences Holdings Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 SWOT Analysis
7.10. Herniamesh S.r.l.
7.10.1 Company Overview
7.10.2 SWOT Analysis
Chapter 8. Winning imperatives of Hernia Mesh Devices Market